http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103265537-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b7dec7a3442e878cdbf561c8433b8a6
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
filingDate 2013-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c27152073aec21288487276818b60e2f
publicationDate 2013-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103265537-A
titleOfInvention Antitumor compound, its preparation method and use
abstract The present invention relates to the field of medicines related to anticancer. Specifically, the present invention relates to an antitumor active compound having the structure of formula I and its preparation method, pharmaceutical composition and use. .
priorityDate 2013-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011094708-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005070589-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4072498-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9842342-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102884051-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148486795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465506757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2727200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428508295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411099766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163805061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416152234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72715603
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425410531

Total number of triples: 26.